UVM Medical Center is the only Vermont hospital offering Tricuspid Transcatheter Edge-to-Edge Repair (TEER) This new heart valve repair procedure brings leading-edge cardiac care closer to home for ...

Left untreated, the condition can lead to heart failure. In October, Powers Health reached a milestone by performing a transcatheter tricuspid valve replacement (TTVR) procedure using the EVOQUE ...

One of those patients is 2-year-old Gigi Leonard, who went through a 10-hour surgery to fix a life-threatening heart condition. NBC 5 spoke with Gigi’s parents and the surgeon who helped her ...

The procedure is designed for patients suffering from mitral regurgitation, a serious heart condition where the mitral valve leaks, allowing blood to flow backwards into the left atrium.

In a clinical trial, the model showed results with accuracy comparable to gold-standard but more-invasive procedures, giving hope to those at risk of heart failure. The condition has recently seen ...

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2024.

Overall, Edwards enjoys a great deal of financial flexibility that would allow for more substantial acquisitions, if those opportunities were to arise. Edwards Lifesciences has come to dominate ...

Q4 2024 Earnings Call Transcript February 11, 2025 Edwards Lifesciences Corporation beats earnings expectations. Reported EPS ...

Edwards Lifesciences reports strong contributions from all product groups ??? TAVR, TTMT and surgical structural heart ??? in ...

Feb. 11, 2025 — Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research has ...

In February 2024, Corewell Health introduced pulsed field ablation, a treatment procedure significantly ... AFib are at increased risk of stroke, heart attack, heart failure, dementia and even ...